Omidenepag

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications

Drug-induced cataract: a real-world study based on the food and drug administration adverse event reporting system database.

Drug-induced cataract: a real-world study based on the food and drug administration adverse event reporting system database.

Journal: Frontiers in medicine
Published: December 02, 2025

Five-Year Outcomes of Omidenepag Isopropyl Monotherapy for Untreated Primary Open-Angle Glaucoma.

Five-Year Outcomes of Omidenepag Isopropyl Monotherapy for Untreated Primary Open-Angle Glaucoma.

Journal: Cureus
Published: November 28, 2025

Topical Omidenepag Isopropyl Lowers Intraocular Pressure in Normal and Glaucomatous Cats: A Pilot Study.

Topical Omidenepag Isopropyl Lowers Intraocular Pressure in Normal and Glaucomatous Cats: A Pilot Study.

Journal: Veterinary ophthalmology
Published: September 27, 2025

Omidenepag Isopropyl-Associated Cystoid Macular Edema After Trabeculectomy.

Omidenepag Isopropyl-Associated Cystoid Macular Edema After Trabeculectomy.

Journal: JAMA ophthalmology
Published: August 07, 2025

Prostaglandin EP2 Receptor and Cystoid Macular Edema in Phakic Posttrabeculectomy Eyes.

Prostaglandin EP2 Receptor and Cystoid Macular Edema in Phakic Posttrabeculectomy Eyes.

Journal: JAMA ophthalmology
Published: August 07, 2025

Myopic Shift Induced By Omidenepag Isopropyl 0.002% in Patients With Primary Open Angle Glaucoma.

Myopic Shift Induced By Omidenepag Isopropyl 0.002% in Patients With Primary Open Angle Glaucoma.

Journal: Journal of glaucoma
Published: June 23, 2025

Diffuse bilateral macular edema associated with omidenepag isopropyl in phakic eyes after laser iridotomy: a case report.

Diffuse bilateral macular edema associated with omidenepag isopropyl in phakic eyes after laser iridotomy: a case report.

Journal: Japanese journal of ophthalmology
Published: May 29, 2025

Benefit of omidenepag isopropyl ophthalmic solution in treatment persistence in Japanese patients with glaucoma.

Benefit of omidenepag isopropyl ophthalmic solution in treatment persistence in Japanese patients with glaucoma.

Journal: Scientific reports
Published: May 01, 2025

Increased Risk of Omidenepag Isopropyl-Induced Cystoid Macular Edema Following Pars Plana Vitrectomy: A Case Report.

Increased Risk of Omidenepag Isopropyl-Induced Cystoid Macular Edema Following Pars Plana Vitrectomy: A Case Report.

Journal: Korean journal of ophthalmology : KJO
Published: April 29, 2025

The Clinical Efficacy of a Topical Selective EP2 Receptor Agonist Against Feline Glaucoma That Is Not Responsive to Conventional Anti-Glaucoma Eyedrops.

The Clinical Efficacy of a Topical Selective EP2 Receptor Agonist Against Feline Glaucoma That Is Not Responsive to Conventional Anti-Glaucoma Eyedrops.

Journal: Veterinary ophthalmology
Published: March 20, 2025

Effectiveness and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution in Treatment-Naive Patients With Primary Open Angle Glaucoma: A Prospective Multicenter Phase IV Study.

Effectiveness and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution in Treatment-Naive Patients With Primary Open Angle Glaucoma: A Prospective Multicenter Phase IV Study.

Journal: Journal of glaucoma
Published: February 03, 2025

Safety and Efficacy of Omidenepag Isopropyl for Elevated Intraocular Pressure: A Systematic Review and Meta-Analysis.

Safety and Efficacy of Omidenepag Isopropyl for Elevated Intraocular Pressure: A Systematic Review and Meta-Analysis.

Journal: American journal of ophthalmology
Published: February 01, 2025
Showing 1-12 of 90

Last Updated: 04/28/2026